- Tytuł:
- No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
- Autorzy:
- Źródło:
- PLoS ONE. 9/5/2018, Vol. 13 Issue 9, p1-12. 12p.
Czasopismo naukowe